Related by context. Frequent words. (Click for all words.) 60 Onno van de Stolpe 58 Sernova 58 J. Donald deBethizy 57 SCOLR Pharma 57 Clay B. Siegall 57 Mersana 56 CardioVascular BioTherapeutics Inc. 56 Sinobiopharma 56 Chemokine Therapeutics 56 ImmunoCellular Therapeutics 55 Æterna Zentaris 55 ANAVEX 55 Dr. Rahul Singhvi 55 TYRX 55 MultiCell Technologies 55 MacroChem 55 Jack Lief Arena 55 John Maraganore Ph.D. 55 MacuSight 55 Genaera Corporation 54 NASDAQ BMTI 54 Transave 54 NASDAQ IPXL today 54 Halozyme Therapeutics 54 Kiadis Pharma 54 Paladin Labs 54 AOBO 54 Jeffrey H. Buchalter 54 PregLem 53 GammaCan 53 Inflazyme 53 PsychoGenics 53 Endovasc 53 QuatRx 53 Opexa 53 TOPIGEN 53 Agile Therapeutics 53 Idera Pharmaceuticals 53 Tianyin Pharmaceutical Co. 53 Celator 53 Relypsa 53 Clearant 53 Aegerion 53 ProtoKinetix 53 Trophos 53 Pyng Medical 52 Aida Pharmaceuticals 52 Cytochroma 52 Syntonix 52 Dynogen 52 iBio 52 Phenoptin 52 Nasdaq ENZN 52 Power3 Medical 52 OMRIX 52 Matthew Emmens 52 Alnara 51 China Aoxing 51 AltheaDx 51 Glenn Saldanha 51 Aegera 51 Transcept Pharmaceuticals 51 BEMA Fentanyl 51 Alzhemed TM 51 CR# vcMMAE 51 AcelRx 51 Applied NeuroSolutions 51 Response Genetics 51 eprotirome 51 Harbor BioSciences 51 MedClean Technologies Inc. 51 Stephen M. Simes 51 Adventrx 51 Jiangbo 51 Nasdaq ADLR 51 Medgenics 51 Medistem 51 Ketotransdel 51 FluoroPharma 51 eniluracil 50 Allovectin 7 ® 50 Genz # 50 HepeX B 50 NASDAQ DYAX 50 forodesine 50 http:/profnet.prnewswire.com/ud public.jsp?useridShuan 50 EKR Therapeutics 50 Phase Ib II 50 Synarc 50 Nanobiotix 50 http:/profnet.prnewswire.com/Subscriber/ExpertProJim Argue 50 HemaCare 50 deforolimus 50 Can Fite 50 MFLEX 50 Cytheris 50 JAK inhibitor 50 Mr. Fater 50 Lung Rx 49 BioPharm Asia 49 QRxPharma